A Phase II Trial of Ofatumumab (CALGB IND) in Previously Untreated Follicular Non-Hodgkin's Lymphoma (NHL)
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 17 Jul 2017
At a glance
- Drugs Ofatumumab (Primary)
- Indications Follicular lymphoma
- Focus Therapeutic Use
- 08 Dec 2015 Pooled exploratory analysis (n=241) of 5 studies including data from this study and 4 other trials (see CTP 700006652, 700009482, 700028982, 70057042) were presented at the 57th Annual Meeting and Exposition of the American Society of Hematology.
- 08 Dec 2015 Results presented at the 57th Annual Meeting and Exposition of the American Society of Hematology
- 09 Jul 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.